Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study

Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study

Various types of botulinum toxin (BoNT) have been studied to treat cervical dystonia (CD). Although high-dose BoNT has proven efficacy, it increases the risk of adverse events. For this reason, this study was planned to identify the non-inferiority efficacy, tolerability, and safety of low-dose neub...

Full description

Bibliographic Details
Main Authors: Subsai Kongsaengdao, Arkhom Arayawithchanont, Kanoksri Samintharapanya, Pichai Rojanapitayakorn, Benchalak Maneeton, Narong Maneeton
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Toxins
Subjects:
abobotulinum toxin A
neubotulinum toxin A
the Toronto Western Spasmodic Torticollis Rating Scale
the Cervical Dystonia Impact Profile
the Short Form 36 health survey questionnaire
the Center for Epidemiological Studies-Depression Scale
Online Access:https://www.mdpi.com/2072-6651/13/10/694

Internet

https://www.mdpi.com/2072-6651/13/10/694

Similar Items